(R)-1-Isothiocyanato-4-(methylsulfinyl)butane CA-NHP Not yet graded
CA licensed ingredient
Market presence12 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-000011
Compound index — R
534 substances begin with R. 2 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 200 of them, (R)-1-Isothiocyanato-4-(me… – Retifanlimab-Dlwr.
US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
(R)-2-Amino-3-mercaptopropanoic acid CA-NHP Not yet graded
CA licensed ingredient
Market presence22 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-000035
(R)-3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt CA-NHP Not yet graded
CA licensed ingredient
Market presence25 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-000064
(R)-5-(1,2-dithiolan-3-yl)pentanoic acid CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-000073
R-alpha-lipoic acid CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012289
R-Lipoic Acid CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012290
Rabacfosadine Succinate US-DRUG Not yet graded
US: drug for further processing
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012291
Rabbit US-DRUG Not yet graded
US: bla
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Animal Fur [CS]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012292
rabbit haemorrhagic disease virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012293
rabbit hemorrhagic disease virus 2 VP1AB EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012294
rabbit hemorrhagic disease virus VP1A EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012295
Rabeprazole Sodium US-DRUG Not yet graded
US: anda
Class as recordedProton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]
Earliest US approval1999
Market presence52 US product listings · 13 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012296
Rabies Virus US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedNitrate Vasodilator [EPC]; Nitrates [CS]; Vasodilation [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012297
Racementhol US-DRUG Not yet graded
US: bulk ingredient
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012298
Racemethionine US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Amino Acid [EPC]; Amino Acids [CS]; Catecholamine [EPC]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012299
Racemethorphan US-CSA Not yet graded
CSA Schedule IInarcotic
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-012300
Racemic Epinephrine HCL CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005725
Racemoramide US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-012301
Racemorphan US-CSA Not yet graded
CSA Schedule IInarcotic
Class as recordedDEA: narcotic / opioid
DEA other namesDromoran
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-012302
Racepinephrine Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Market presence11 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012303
Ractopamine Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012304
RAD-140 ETALYN E/insufficientband 6
also: testolone; developed as vosilasarm
Recorded from — 0 of 7 registers
Etalyn identifierETA-C-012305
rADAMTS13 EU-MED Not yet graded
EU medicine: Authorised
Class as recordedB01AD13
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012306
Radis noir: Raphanus niger (Black radish) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Usually recognized for helping digestion. Usually recognized for helping transit” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-012307
Radish US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Calculi Dissolution Agent [EPC]
Market presence30 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012308
radium (223Ra) dichloride EU-MED Not yet graded
EU medicine: Authorised
Class as recordedV10XX03
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012311
Radium Bromatum CA-NHP Not yet graded
CA licensed ingredient
Market presence9 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012310
Radium Bromide US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]; Anti-coagulant [EPC]
Market presence28 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012309
Radium RA-223 Dichloride US-DRUG Not yet graded
US: nda
Class as recordedRadioactive alpha-Particle Emitting Therapeutic Agent [EPC]; alpha-Particle Emitting Activity [MoA]
Earliest US approval2013
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012312
Radix Achyranthis Bidentatae CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012313
Radix Ampelopsis CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012314
Radix Aucklandiae CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012315
Radix bupleuri CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012316
Radix Codonopsis CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012317
Radix curcumae CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012318
Radix et rhizoma asari CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012319
Radix et Rhizoma Rhei CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012320
Radix Glycyrrhizae CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012321
Radix Glycyrrhizae Uralensis CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012322
Radix Ophiopogonis CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012323
Radix Platicodonis CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012324
Radix Rehmanniae Glutinosae Conquitae CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012325
Radix rehmanniae preparata CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012326
Radix Scrophulariae CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012327
Radix Scutellariae CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012328
Radix trichosanthis CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012329
Rainbow Trout US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012330
Raloxifene Hydrochloride EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedEstrogen Agonist/Antagonist [EPC]; G03XC01; Selective Estrogen Receptor Modulators [MoA]
Earliest US approval1997
Market presence39 US product listings · 10 FDA applications · 3 EU medicines
Etalyn identifierETA-C-012331
raltegravir EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, WithdrawnUS: anda
Class as recordedHIV Integrase Inhibitors [MoA]; Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]; J05AJ01; J05AR16
Earliest US approval2007
Market presence22 US product listings · 6 FDA applications · 2 EU medicines
Etalyn identifierETA-C-012332
Ramatercept US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012333
Ramelteon US-DRUG Not yet graded
US: anda
Class as recordedMelatonin Receptor Agonist [EPC]; Melatonin Receptor Agonists [MoA]
Earliest US approval2005
Market presence54 US product listings · 12 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012334
Ramipril US-DRUG Not yet graded
US: anda
Class as recordedAngiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]
Earliest US approval1991
Market presence82 US product listings · 20 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012335
Ramucirumab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedL01FX06; VEGFR2 Inhibitors [MoA]; Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]
Earliest US approval2014
Market presence5 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-012336
Rancid Beef US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Acidifying Activity [MoA]; Actively Acquired Immunity [PE]
Market presence112 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012337
Ranibizumab EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: bla
Class as recordedS01LA04; Vascular Endothelial Growth Factor Inhibitor [EPC]; Vascular Endothelial Growth Factor Inhibitors [MoA]
Earliest US approval2006
Market presence18 US product listings · 2 FDA applications · 10 EU medicines
Etalyn identifierETA-C-012338
Ranibizumab-Eqrn US-DRUG Not yet graded
Earliest US approval2022
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012339
Ranibizumab-Hkdz US-DRUG Not yet graded
Earliest US approval2026
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012340
Ranibizumab-Leyk US-DRUG Not yet graded
Earliest US approval2025
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012341
Ranibizumab-Nuna US-DRUG Not yet graded
Earliest US approval2021
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012342
Ranitidine US-DRUG Not yet graded
US: anda
Class as recordedHistamine H2 Receptor Antagonists [MoA]; Histamine-2 Receptor Antagonist [EPC]
Earliest US approval1983
Market presence24 US product listings · 85 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012343
Ranitidine Bismuth Citrate US-DRUG Not yet graded
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012344
Ranolazine EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedAnti-anginal [EPC]; C01EB18; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]
Earliest US approval2006
Market presence78 US product listings · 29 FDA applications · 1 EU medicines
Etalyn identifierETA-C-012345
Ranunculus acris CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012346
Ranunculus Bulbosus CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: drug for further processing
Class as recordedAllergens [CS]; Analogs/Derivatives [Chemical/Ingredient]; Bee Venoms [CS]; Blood Coagulation Factor [EPC]
Market presence47 US product listings · 45 Canadian licensed products
Etalyn identifierETA-C-012347
Ranunculus Bulbosus Root US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fruit Proteins [EXT]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012348
Ranunculus Bulbosus Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Actively Acquired Immunity [PE]; Adenovirus [Chemical/Ingredient]; Allergens [CS]
Market presence32 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012349
Ranunculus Ficaria CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence1 US product listings · 2 Canadian licensed products
Etalyn identifierETA-C-012350
Ranunculus Glacialis Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012351
Ranunculus sceleratus CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012352
Ranunculus ternatus CA-NHP Not yet graded
CA licensed ingredient
Market presence25 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012353
Rapacuronium Bromide US-DRUG Not yet graded
Earliest US approval1999
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012354
Rapana venosa EU-NOVEL Not yet graded
Not novel in food
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-012355
Rapeseed oil EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Rapeseed oil helps to control cholesterol” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-012356
Raphanus Raphanistrum Whole US-DRUG Not yet graded
US: drug for further processing
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012357
Raphanus rusticanus L. CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012358
Raphanus Sativus CA-NHPEU-NOVELUS-DRUG Not yet graded
Not novel in foodCA licensed ingredientUS: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]
Market presence2 US product listings · 324 Canadian licensed products
Parts in scopeseed capsules/siliques and roots; Flowers and leaves
Etalyn identifierETA-C-012359
Raphanus sativus - common name : radish, black radish, Japanese radish, Daikon EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “"Used to facilitate the digestion" "Helps to support normal liver function" "Contributes to the stimulation of the production of the digestive body fluids" "Supports the liver and biliary function" "Contributes to the digestive comfort" "Helps to facilitate fat digestion" "Contributes to better fat digestion" "Helps to support the digestion" "Contributes to support the digestion".” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-012360
Raphanus sativus niger CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012361
Raphanus sativus var. niger CA-NHPEU-CLAIM Not yet graded
EU claims 0 authorised / 1 refusedCA licensed ingredient
Market presence20 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Contributes to the elimination function of the gastrointestinal tract / contributes to bile flow fonction / supports healthy liver activity / contributes to healthy digestion/digestive well-beingl/liver well-being.” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-012362
Raphanus sativus var. sativus CA-NHP Not yet graded
CA licensed ingredient
Market presence47 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012363
Raphanus Sativus Var. Sativus Seed US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012364
Rapsöl (einfach ungesättigte Fettsäuren) EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Einfach ungesättigte Fettsäuren halten die Arterien elastisch. Clarification provided Monounsaturated fatty acids keep arteries elastic. Example of wording: Monounsaturated fatty acids improve blood lipid levels. Monounsaturated fatty acids have a positive effect on blood lipid levels. Monounsaturated fatty acids stabilize blood lipid levels. Monounsaturated fatty acids maintain HDL cholesterol at constant levels…” | Non-authorised | Art.13(1) | EFSA opinion |
| “Einfach ungesättigte Fettsäuren halten die Arterien elastisch. Clarification provided Monounsaturated fatty acids keep arteries elastic. Example of wording: Monounsaturated fatty acids improve blood lipid levels. Monounsaturated fatty acids have a positive effect on blood lipid levels. Monounsaturated fatty acids stabilize blood lipid levels. Monounsaturated fatty acids maintain HDL cholesterol at constant levels…” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-012365
Rasagiline EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedMonoamine Oxidase Inhibitor [EPC]; Monoamine Oxidase Inhibitors [MoA]; N04BD02
Earliest US approval2006
Market presence42 US product listings · 14 FDA applications · 2 EU medicines
Etalyn identifierETA-C-012366
Raspberry US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fruit Proteins [EXT]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012368
Rat dropping CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012369
Ratanhia CA-NHP Not yet graded
CA licensed ingredient
Market presence31 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012370
Rattus Norvegicus Hair US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Animal Fur [CS]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012371
Rattus Norvegicus Skin US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Cells; Epidermal [EXT]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012372
Rauwolfia Serpentina CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]
Market presence21 US product listings · 23 Canadian licensed products
Etalyn identifierETA-C-012373
Rauwolfia Serpentina Root US-DRUG Not yet graded
Earliest US approval1954
Market presence19 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012374
Rauwolfia vomitoria EU-NOVEL Not yet graded
Novel, not yet authorised
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-012375
Ravulizumab-Cwvz US-DRUG Not yet graded
US: drug for further processing
Earliest US approval2018
Market presence2 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012377
Raw or processed food products of animal origin, plus bread and panification products (cow's, goat's and ewe's milk and related products ( milk, cream, butter, cheese, yoghurt, fresh dairy products); hen's and quail's eggs; beef's, veal's and lamb's me EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “* The Tradilin network makes it possible to obtain products which fit into a diet naturally rich in omega 3 which participates to improve/decrease carbohydrate metabolic disorders La filière Tradilin permet d'obtenir des produits qui s'intègrent dans une alimentation riche en Oméga 3 qui participe diminuer les désordres du métabolisme des carbohydrates * The Tradilin network makes it possible to obtain products…” | Non-authorised | Art.13(1) | EFSA opinion |
| “* The Tradilin network makes it possible to obtain products which fit into a diet naturally rich in omega 3, which favors the balance/a good balance of blood lipids La filière Bleu-Blanc-Coeur / Tradilin permet d'obtenir des produits qui s'intègrent dans une alimentation naturellement riche en oméga 3, qui favorise l'équilibre des lipides sanguins * A diet which includes products from the Tradilin network favours a…” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-012378
Raxibacumab US-DRUG Not yet graded
US: bla
Class as recordedAnthrax Protective Antigen-directed Antibody Interactions [MoA]; Anthrax Protective Antigen-directed Antibody [EPC]
Earliest US approval2012
Market presence2 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012379
reassortant influenza virus (live attenuated) of the following strain: A/Vietnam/1203/2004 (H5N1) strain EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07BB03
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012380
reassortant influenza virus (live attenuated) of the following strains:A/California/7/2009 (H1N1)pdm09 like strain EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedJ07BB03
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012381
Rebamipide US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012382
Reboxetine Mesylate US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012383
recombinant EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07BB02; J07BN04
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012384
recombinant adenovirus type 26 (Ad26) encoding the glycoprotein (GP) of the Ebola virus Zaire (ZEBOV) Mayinga strain EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedJ07
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012385
recombinant chimeric porcine circovirus 1 containing the porcine circovirus 2a open reading frame 2 protein EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012386
Recombinant chimeric porcine circovirus 1 containing the porcine circovirus 2b open reading frame 2 protein EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012387
recombinant cholera toxin B subunit EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07AE01
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012388
recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012389
recombinant human C1-inhibitor EU-MED Not yet graded
EU medicine: Authorised, Refused
Class as recordedB06AC04; B06C
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012390
recombinant human interferon alfa-2a EU-MED Not yet graded
EU medicine: Refused
Class as recordedL03AB04
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012391
recombinant human monoclonal antibody to hsp EU-MED Not yet graded
EU medicine: Refused
Class as recordedJ02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012392
recombinant human n-acetylgalactosamine-6-sulfatase EU-MED Not yet graded
EU medicine: Authorised
Class as recordedA16AB12
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012393
recombinant human nerve growth factor EU-MED Not yet graded
EU medicine: Authorised
Class as recordedS01
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012394
recombinant inactivated avian influenza virus EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedQI01AA23
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012395
recombinant Modified Vaccinia Ankara Bavarian Nordic Virus encoding the: Ebola virus Zaire (ZEBOV) Mayinga strain glycoprotein (GP) EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedJ07BX
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012396
recombinant Neisseria meningitidis group B fHbp fusion protein EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07AH09
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012397
recombinant Neisseria meningitidis group B NadA protein EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07AH09
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012398
recombinant Neisseria meningitidis group B NHBA fusion protein EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07AH09
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012399
recombinant omega interferon of feline origin EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012400
recombinant pertussis toxin EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07AJ02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012401
recombinant protein Q from Leishmania infantum MON-1 EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012402
recombinant salmon calcitonin EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedH05BA01
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012403
recombinant SARS CoV2 spike protein EU-MED Not yet graded
EU medicine: Application withdrawn
Class as recordedQI20CX
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012404
Recombinant Stabilized RSV A Prefusion F Antigen US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012405
Recombinant Stabilized RSV B Prefusion F Antigen US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012406
recombinant Streptococcus equi protein CCE EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012407
recombinant Streptococcus equi protein Eq85 EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012408
recombinant Streptococcus equi protein IdeE EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012409
recombinant surface antigen EU-MED Not yet graded
EU medicine: Authorised, Withdrawn
Class as recordedJ07BC01; J07CA
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012410
recombinant turkey herpesvirus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012411
recombinant type-D Pasteurella-multocida toxin EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012412
recombinant varicella zoster virus glycoprotein E EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07BK03
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012413
Recombinant Varicella Zoster Virus Glycoprotein E Antigen US-DRUG Not yet graded
US: bla
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012414
recombinant Verotoxin 2e of E. coli EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012415
recombinant vesicular stomatitis virus (strain indiana) with a deletion of the envelope glycoprotein EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012416
Red bioflavonoids CA-NHP Not yet graded
CA licensed ingredient
Market presence8 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012417
Red bone marrow CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012418
Red clay sea salt EU-NOVEL Not yet graded
Not novel in food
also: Alaea salt; Hawaiian red salt
Parts in scopeSubstance
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-012419
Red clover CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012420
Red Clover Isoflavone Extract CA-NHP Not yet graded
CA licensed ingredient
Market presence135 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012421
Red clover isoflavones CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012422
Red King Crab US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012423
Red mercuric sulfide CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012424
Red Spinach CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012425
Red wine extract CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012426
Red Wine Polyphenol Extract CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012427
Red yeast rice CA-NHP Not yet graded
CA licensed ingredient
Market presence21 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012428
Reduced L-Glutathione CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012429
Reduced minerals whey CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012430
Reductic Acid US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012431
Regadenoson EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedAdenosine Receptor Agonist [EPC]; Adenosine Receptor Agonists [MoA]; C01EB21; Pharmacologic Cardiac Stress Test Agent [EPC]
Earliest US approval2008
Market presence24 US product listings · 14 FDA applications · 1 EU medicines
Etalyn identifierETA-C-012433
regdanvimab EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedJ06BD06
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012434
Regorafenib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2C9 Inhibitors [MoA]; Kinase Inhibitor [EPC]; Kinase Inhibitors [MoA]
Earliest US approval2012
Market presence6 US product listings · 3 FDA applications · 1 EU medicines
Etalyn identifierETA-C-012435
regulat®.pro.kid IMMUN, food supplement with fermented vegetables and fruits, probiotics lecithin and rhodiola rosea extract EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “regulat®.pro.kid IMMUN supports, stimulates and modulates the immune system of children during growth.” | Non-authorised | Art.14(1)(b) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-012437
regulat®.pro.kid.BRAIN, food supplement with probiotics and fermented vegetables and fruits EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “regulat®.pro.kid.BRAIN contributes to mental and cognitive development of children” | Non-authorised | Art.14(1)(b) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-012436
Rehmannia CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012438
Rehmannia glutinosa CA-NHP Not yet graded
CA licensed ingredient
Market presence2,232 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012439
Rehmannia glutinosa preparated CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012440
Rehmannia Glutinosa Root US-DRUG Not yet graded
US: otc monograph drug
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012441
Rein CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012442
Reishi US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAllergens [CS]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012443
Reishi mushroom CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012444
Relacorilant US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval2026
Market presence3 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012445
Relatlimab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedL01FY02; Lymphocyte Activation Gene-3 Antagonists [MoA]; Lymphocyte Activation Gene-3 Blocker [EPC]; Programmed Death Receptor-1 Blocking Antibody [EPC]
Market presence2 US product listings · 1 EU medicines
Etalyn identifierETA-C-012446
Relatlimab-Rmbw US-DRUG Not yet graded
Earliest US approval2022
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012447
Relebactam EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient for human prescription compounding
Class as recordedCarbapenems [CS]; Dipeptidase Inhibitors [MoA]; J01DH56; Penem Antibacterial [EPC]
Earliest US approval2019
Market presence3 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-012448
relfovetmab EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012449
Relugolix EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 3A Inducers [MoA]; Decreased GnRH Secretion [PE]
Earliest US approval2020
Market presence13 US product listings · 2 FDA applications · 2 EU medicines
Etalyn identifierETA-C-012450
Remdesivir EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedJ05AB16; SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]
Earliest US approval2020
Market presence9 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-012451
Remibrutinib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedBruton's Tyrosine Kinase Inhibitors [MoA]; Kinase Inhibitor [EPC]; L04AA60; P-Glycoprotein Inhibitors [MoA]
Earliest US approval2025
Market presence2 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-012452
Remifentanil US-CSAUS-DRUG Not yet graded
CSA Schedule IInarcoticUS: anda
Class as recordedDEA: narcotic / opioid; Full Opioid Agonists [MoA]; Opioid Agonist [EPC]
Earliest US approval1996
Market presence19 US product listings · 4 FDA applications
DEA other namesUltiva
Etalyn identifierETA-C-012453
Remimazolam (4H-imidazol[1,2-a][1,4]benzodiazepine-4-propionic acid) benzenesulfonate (1:1); methyl 3-[(4S)-8-bromo-1- US-CSA Not yet graded
CSA Schedule IV
also: Remimazolam benzenesulfonate ; methyl 3-[ -8-bromo-1-
Class as recordedDEA: depressant
DEA other names8-Bromo-1-methyl-6-(2-pyridinyl)-(4S)-methyl ester,; methyl-6-pyridin-2-yl-4H-imidazo[1,2-; a][1,4]benzodiazepin-; 4yl]propanoate benzenesulfonic acid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-012455
Ren Shen CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012456
Renal calculi CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012457
Renin US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012458
Rennet CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012459
Repaglinide EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: anda
Class as recordedA10BX02; Glinide [EPC]; Potassium Channel Antagonists [MoA]
Earliest US approval1997
Market presence31 US product listings · 11 FDA applications · 7 EU medicines
Etalyn identifierETA-C-012460
replaced with the zaire ebolavirus (strain kikwit 1995) surface glycoprotein EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012461
Repository Corticotropin US-DRUG Not yet graded
Earliest US approval2010
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012462
Repotrectinib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedCytochrome P450 3A4 Inducers [MoA]; Kinase Inhibitor [EPC]; L01EX28; Proto-Oncogene Tyrosine-Protein Kinase ROS1 Inhibitors [MoA]
Earliest US approval2023
Market presence8 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-012463
Rescinnamine US-DRUG Not yet graded
Earliest US approval1956
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012464
Reserpine US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1954
Market presence2 US product listings · 101 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012465
Resina Ferulae CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012466
Resina laricis CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012467
Resistant maltodextrin CA-NHP Not yet graded
CA licensed ingredient
Market presence17 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012468
Resistant maltodextrins CA-NHP Not yet graded
CA licensed ingredient
Market presence117 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012469
Resistant starch EU-CLAIM Not yet graded
EU claims 1 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Replacing digestible starches with resistant starch in a meal contributes to a reduction in the blood glucose rise after that meal.” | Authorised | Art.13(1) | EFSA opinion |
| “Resistant starch helps favour a normal colon metabolism; Resistant starch is a butyrogenic fibre, butyrate participates to a normal colonic functions and metabolism” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-012470
Resistant starch- type 2 (RS) from high amylose maize EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “RS promotes a healthy digestive system. RS delivers prebiotic activities.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-012471
Reslizumab EU-MEDUS-DRUG Not yet graded
Resmetirom EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedA05; Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]
Earliest US approval2024
Market presence15 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-012473
resminostat mesilate EU-MED Not yet graded
EU medicine: Opinion
Class as recordedL01X
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012474
resocortol butyrate EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedQD07AC90
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012475
Resorcinol CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: otc monograph drug
Class as recordedAcidifying Activity [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]
Market presence29 US product listings · 5 Canadian licensed products
Etalyn identifierETA-C-012476
Resorcinum CA-NHP Not yet graded
CA licensed ingredient
Market presence12 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012477
respiratory syncytial virus vaccine (bivalent, recombinant) EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07BX05
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012478
Resveratrol CA-NHPEU-CLAIMEU-NOVELUS-DRUG Not yet graded
Not novel in supplementsEU claims 0 authorised / 1 refusedCA licensed ingredientUS: bulk ingredient for human prescription compounding
Market presence1 US product listings · 30 Canadian licensed products
Parts in scopeSubstance
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Due to its antioxidant activity, resveratrol contributes to cell protection from the damage caused by free radicals. Provides antioxidant protection. Helps to scavenge free radicals which are responsible for skin aging. Helps to fight against skin aging thanks to its antioxidant activity.” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-012479
Retatrutide ETALYNUS-DRUG C/supportedband 2
US: bulk ingredient
Market presence12 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012481
Retifanlimab EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: bla
Class as recordedL01FF10; L01FX06; Programmed Death Receptor-1 Blocking Antibody [EPC]; Programmed Death Receptor-1-directed Antibody Interactions [MoA]
Market presence2 US product listings · 1 EU medicines
Etalyn identifierETA-C-012483
Retifanlimab-Dlwr US-DRUG Not yet graded
Earliest US approval2023
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012484